Adaptive Biotechnologies Corp. (ADPT)
25.54
-0.45
(-1.73%)
USD |
NASDAQ |
Aug 24, 16:00
25.54
0.00 (0.00%)
After-Hours: 20:00
Adaptive Biotechnologies Total Assets (Quarterly) : 640.68M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 640.68M |
| March 31, 2026 | 505.94M |
| December 31, 2025 | 964.03M |
| September 30, 2025 | 490.61M |
| June 30, 2025 | 496.64M |
| March 31, 2025 | 510.85M |
| December 31, 2024 | 539.38M |
| September 30, 2024 | 558.51M |
| June 30, 2024 | 584.87M |
| March 31, 2024 | 620.32M |
| December 31, 2023 | 661.13M |
| September 30, 2023 | 717.68M |
| June 30, 2023 | 764.54M |
| March 31, 2023 | 791.46M |
| December 31, 2022 | 856.62M |
| Date | Value |
|---|---|
| September 30, 2022 | 884.21M |
| June 30, 2022 | 806.63M |
| March 31, 2022 | 858.19M |
| December 31, 2021 | 923.34M |
| September 30, 2021 | 992.61M |
| June 30, 2021 | 1.033B |
| March 31, 2021 | 1.072B |
| December 31, 2020 | 1.116B |
| September 30, 2020 | 1.095B |
| June 30, 2020 | 854.82M |
| March 31, 2020 | 874.89M |
| December 31, 2019 | 912.30M |
| September 30, 2019 | 917.39M |
| June 30, 2019 | 601.40M |
| March 31, 2019 | 614.58M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Personalis, Inc. | 312.14M |
| 10X Genomics, Inc. | 1.030B |
| Alamar Biosciences, Inc. (California) | 390.98M |
| Champions Oncology, Inc. | 26.99M |
| Medpace Holdings, Inc. | 2.057B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 490.02M |
| Shareholders Equity (Quarterly) | 142.91M |
| Debt to Equity Ratio | 2.872 |
| Current Ratio | 4.795 |
| Net Debt Paydown Yield | -1.11% |